You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 1, January 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Epilepsy
 •Neurogenetics
 •Pediatric Neurology
 •Alert me on articles by topic

Juvenile Alpers Disease

Esko Wiltshire, MD, FRACP; Guido Davidzon, MD; Salvatore DiMauro, MD; Hasan O. Akman, PhD; Lynette Sadleir, MD, FRACP; Lindsay Haas, MBChB, FRACP; Jane Zuccollo, MBBChBAO, FRCPA; Alison McEwen, BA, FHGSA; David R. Thorburn, PhD

Arch Neurol. 2008;65(1):121-124.

Background  Alpers disease is commonly associated with polymerase {gamma} deficiency and usually affects infants or young children.

Objective  To report a juvenile case of Alpers disease due to mutations in the polymerase {gamma} gene (POLG1).

Design  Clinical, pathologic, biochemical, and molecular analysis.

Setting  Tertiary care university hospital and academic institutions.

Patient  A 17-year-old adolescent girl with intractable epilepsy and liver disease.

Main Outcome Measures  Clinical course and pathologic, biochemical, and molecular features.

Results  Biochemical and pathologic evidence suggested a respiratory chain defect, which was confirmed by enzyme analysis of the liver. Mutational analysis of POLG1 showed 2 novel mutations: T851A and R1047W.

Conclusion  The POLG1 mutations can cause juvenile and childhood Alpers disease.


Author Affiliations: Departments of Pediatrics and Child Health (Drs Wiltshire and Sadleir) and Pathology (Dr Zuccollo), Wellington School of Medicine and Health Sciences, University of Otago, and Central Regional Genetics Service (Dr Wiltshire and Ms McEwen) and Department of Neurology (Ms Haas), Capital and Coast District Health Board, Wellington, New Zealand; Department of Neurology, Columbia University Medical Center, New York, New York (Drs Davidzon, DiMauro, and Akman); and Murdoch Childrens Research Institute and Genetic Health Services Victoria, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne, Australia (Dr Thorburn).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.